Comparative Pharmacology
Head-to-head clinical analysis: DICYCLOMINE HYDROCHLORIDE PRESERVATIVE FREE versus FRINDOVYX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DICYCLOMINE HYDROCHLORIDE PRESERVATIVE FREE versus FRINDOVYX.
DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE FREE) vs FRINDOVYX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Competitive antagonist of muscarinic acetylcholine receptors (M1, M2, M3) in the gastrointestinal tract, producing antispasmodic effects by reducing smooth muscle contractions.
Frindovyx is a selective serotonin reuptake inhibitor (SSRI) that potentiates serotonergic activity in the central nervous system by inhibiting the reuptake of serotonin at the synaptic cleft.
20 mg intramuscularly every 4-6 hours.
10 mg orally once daily.
None Documented
None Documented
5-8 hours; may be prolonged in elderly or patients with hepatic impairment
Terminal elimination half-life is 12-15 hours in patients with normal renal function; prolonged to 24-30 hours in moderate renal impairment (CrCl 30-50 mL/min) and up to 48 hours in severe impairment (CrCl <30 mL/min).
Renal (approximately 50-80% as unchanged drug and metabolites), biliary/fecal (minor, <10%)
Renal excretion of unchanged drug accounts for approximately 60% of the administered dose, with an additional 30% recovered as inactive metabolites in urine. Fecal/biliary elimination constitutes the remaining 10%.
Category A/B
Category C
Anticholinergic
Anticholinergic